Monday, November 13, 2017
Print Current Session:
|
|
Monday
SESSION 5:
INTERVENTIONAL ONCOLOGY
Location: Murray Hill Suites East and West, 2nd Floor
Moderators:Amy R. Deipolyi, MD, PhD / Ernest J. Ring, MD |
|
SESSION 5 SCHEDULE | |
2:00 PM - 2:10 PM | New Angiographic Imaging Tools And Devices That Enhance IO: What Is A Must And What Would Be Nice |
Presenter(s):Edward Kim, MD Location: Murray Hill Suites East and West, 2nd Floor |
|
View Slides in PDF | |
2:10 PM - 2:20 PM | Beyond Sirafenib, Regorafenib, (STIVARGA): Results Of The RESORCE Trial And How Will It Affect Interventional Treatment Of HCC |
Presenter(s):Kevin Kim, MD Location: Murray Hill Suites East and West, 2nd Floor |
|
View Slides in PDF | |
2:20 PM - 2:30 PM | Techniques and Technology For Intraprocedural Confirmation Of Adequacy Of Intravascular Treatment Of HCC |
Presenter(s):Jean Francois H. Geschwind, MD Location: Murray Hill Suites East and West, 2nd Floor |
|
View Slides in PDF | |
2:30 PM - 2:40 PM | Same Day Y90: Is It Feasible, Practical, And Economical? |
Presenter(s):Robert J. Lewandowski, MD Location: Murray Hill Suites East and West, 2nd Floor |
|
View Slides in PDF | |
2:40 PM - 2:50 PM | Y90 Lobectomy Has Many Advantages Over PVE: Why, When, And How I Do It |
Presenter(s):Riad Salem, MD, MBA Location: Murray Hill Suites East and West, 2nd Floor |
|
View Slides in PDF | |
2:50 PM - 3:00 PM | Tumor Embolization And PVE Is The Best Procedure To Enlarge The Future Liver Remnant |
Presenter(s):David C. Madoff, MD Location: Murray Hill Suites East and West, 2nd Floor |
|
View Slides in PDF | |
3:00 PM - 3:10 PM | Locoregional Therapy May Be Limited By Liver Function: Predicting Outcomes Based On Pre-Procedure Clinical And Lab Results |
Presenter(s):Nishita Kothary, MD Location: Murray Hill Suites East and West, 2nd Floor |
|
View Slides in PDF | |
3:10 PM - 3:20 PM | Management Of Tumor With AV Shunting And/Or Macrovascular Invasion |
Presenter(s):Edward Kim, MD Location: Murray Hill Suites East and West, 2nd Floor |
|
View Slides in PDF | |
3:20 PM - 3:30 PM | Panel Discussion |
END OF SESSION 5 | |
previous | next |